From the Editor - Volume 32, Issue

The D’s of robotics: Are we ready to delegate?  When Shiri Diskin and Daniela Kamir suggested in 2021 to have a Medical Writing issue on automation in medical writing, little did I imagine how imperative this topic would be in 2023. I sincerely…

Regulatory Matters - Volume 34, Issue

Section Editors: Clare Chang, Zuo Yen Lee

The AI-enabled medical writer: A new era for regulatory writing

Authors: Jenni Pickett, Vanessa de Langsdorff

As artificial intelligence (AI) becomes increasingly integrated into the pharma ceutical industry,…

Never P alone: The value of estimates and confidence intervals - Volume 25, Issue

How results are reported influences how they are interpreted. Although P values have been granted great importance, they have no clinical interpretation. Rather, they are a measure of chance as an explanation for the results. Their either or…

Medical Communications - Volume 23, Issue

I must admit to feeling very strongly about information that is written for patients – both about the quality and the appropriateness of the information itself, and about how it is communicated. Thankfully, this topic is now enjoying some long…

The Webscout - Volume 26, Issue

“11 tips to write better”, “10 fast ways to become a better writer”, and “5 unconventional ways to become a better writer”. These are examples of what a Google search for “write better” gives you. Some read quite reasonably, some are rather awkward.…

How to write for health websites - Volume 30, Issue

Medical writing for the internet is unique because of the way people find and consume online content. Unlike with a medical brochure handed to someone by their doctor or a hard copy of the latest health book that they’ve purchased, individuals are…

Silenced data: How banning words undermines real-world evidence in medical writing - Volume 34, Issue

Executive orders (EOs) issued by the President of the United States can significantly shift federal research priorities, funding allocations, and public health directives, thereby influencing which medical topics receive attention and resources. EOs…

For the greater good…Can agency competitors cooperate to advance medical publication practices? - Volume 24, Issue

The business of medical writing is competitive, but can it be cooperative? Is it time for agencies, which provide professional and ethical publication support to authors, to cooperate for the greater good of the medical publication profession?…

Registration and ethics committee approval for observational studies: Current status and way forward - Volume 26, Issue

Randomised controlled trials (RCTs) have always been recognised as the highest level of evidence in medical research. However, they cannot address the questions that one comes across in real-world clinical practice. Observational studies can answer…

The UK pharmaceutical industry braces for Brexit, be it mild, severe, or doomsday - Volume 27, Issue

Pharma-Brexit is on its way. The announcement of the European Medicine Agency’s move to Amsterdam, various UK government white papers, and comments made by key stakeholders in the UK pharmaceutical industry have led to a wide range of predictions…